These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5934635)

  • 1. Susceptibility of burned mice to Pseudomonas aeruginosa and protection by vaccination.
    Millican RC; Evans G; Markley K
    Ann Surg; 1966 Apr; 163(4):603-10. PubMed ID: 5934635
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract]   [Full Text] [Related]  

  • 6. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ; Lowbury EJ
    Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pyocyanic infection in burned patients. Immunitary protection].
    Moyen EN; Lesage D; Romano P
    Nouv Presse Med; 1972 Apr; 1(14):947-50. PubMed ID: 4623061
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J; Fisher A; Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of burned mice challenged with pseudomonas by peritoneal exudate cells.
    Markley K; Smallman E
    J Reticuloendothel Soc; 1969; 6(5):448-56. PubMed ID: 4981624
    [No Abstract]   [Full Text] [Related]  

  • 12. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral antibody response to Pseudomonas aeruginosa in a burned mouse model.
    Subramaniam L; Shriniwas ; Kumar R; Bhujwala RA
    Indian J Med Res; 1985 Dec; 82():498-501. PubMed ID: 3938772
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.
    Yang F; Gu J; Yang L; Gao C; Jing H; Wang Y; Zeng H; Zou Q; Lv F; Zhang J
    Sci Rep; 2017 Jun; 7(1):3957. PubMed ID: 28638106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
    Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
    Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
    Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against Pseudomonas infection in burned patients: aspects and problems.
    Taidelli G; Savani A; Grisotti A
    Acta Chir Plast; 1971; 13(2):94-9. PubMed ID: 4106415
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model.
    Laghaei P; Hashemi FB; Irajian G; Korpi F; Amirmozafari N; Behrouz B
    Mol Immunol; 2016 Jun; 74():71-81. PubMed ID: 27152476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.
    Saelinger CB; Snell K; Holder IA
    J Infect Dis; 1977 Oct; 136(4):555-61. PubMed ID: 409788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.